Gore Innovation Center Announces Collaboration With Robotics Startup Moray Medical

Founded by materials science company W. L. Gore & Associates (Gore), the Gore Innovation Center leverages the company’s 60 years of engineering expertise to help startups pursue new concepts and ideas, build prototypes, test material sets and explore a world of possibilities. Proven to withstand the harshest environments and exacting requirements of aerospace, sustainability, medical and energy applications (to name a few), Gore delivers both pioneering solutions and trusted mission-critical materials that have been relied on for decades — including its revolutionary GORE-TEX Fabric.

Lab use case – robotics in healthcare

In July 2019, Moray Medical was named a Rosenman Innovator for its innovative technology and patient impact. An esteemed panel of subject matter experts, clinicians, and investors selected Moray Medical for digitizing the user interface of cardiac catheter systems to enable precise delivery of therapies within the beating hearts of millions of patients. Additionally, Moray Medical was awarded time in the Gore Innovation Center prototyping lab to test, build, and enhance its robotic catheter system in the Gore Innovation Center prototyping lab.

Today, Moray Medical is leveraging the prototyping lab to deliver transformative breakthroughs at scale. The lab offers broad ideation, testing, and manufacturing capabilities — including additive and subtractive manufacturing, wet chemistry, analytical tools, and more.

“The Gore Innovation Center offers deep engineering expertise and foundational capabilities that have helped us drive our idea forward,” said Phillip Laby, co-founder, Moray Medical. “We have made significant advancements on bringing robotic dexterity, precision and ease-of-use to a range of therapies.”

Gore Innovation Center startup application

Silicon Valley startups working on breakthroughs in sustainable technologies and advanced materials are encouraged to apply for workspace now through March 31, 2020. Technology focus areas for 2020 include, but aren’t limited to:

  • Advanced materials
  • Clean technology
  • Neurostimulation and bioelectronics
  • Sustainable fabrics

Who qualifies?

The Gore Innovation Center seeks nimble, forward-looking startups to collaborate on the development of industry-leading products. Applications from hard tech science startups, from seed to series A, that embody novel technologies and will benefit from Gore expertise are encouraged.

“Combining deep materials science expertise with market insights, the Gore Innovation Center helps startups accelerate their technology development,” said Linda Elkins, leader, Gore Innovation Center. “Gore materials are a core component for many everyday products. Our scientists can independently alter specific material attributes such as microstructure, thickness, modulus, and form factor to achieve desired performance in a variety of applications.”

To apply to work in the Gore Innovation Center prototyping lab, visit: https://www.research.net/r/GoreSVICapplication

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”